Back to top
more

UnitedHealth Group (UNH)

(Real Time Quote from BATS)

$247.23 USD

247.23
1,008,824

-3.77 (-1.50%)

Updated Aug 6, 2025 09:52 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 1% (243 out of 246)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.

Sheraz Mian headshot

Are Stocks 'Irrationally Exuberant'?

by Sheraz Mian

It is a hard argument to make when earnings estimates are going up and interest rates remain accommodative.

    Zacks Equity Research

    Higher Optum Revenues to Drive UnitedHealth (UNH) Q4 Earnings

    by Zacks Equity Research

    Increased contribution across Optum's segments should support UnitedHealth's (UNH) earnings in Q4.

      Zacks Equity Research

      UnitedHealth's Q4 Earnings to Benefit From Higher Enrollment

      by Zacks Equity Research

      Higher membership across UnitedHealth's (UNH) government business, partially offset by a decline in enrollment in Commercial and Global operations will drive growth.

        Zacks Equity Research

        Robust Revenues to Drive UnitedHealth's (UNH) Q4 Earnings

        by Zacks Equity Research

        UnitedHealth's (UNH) Q4 earnings are likely to gain traction from improved enrollment, higher revenues from health service and benefit business plus a strong capital management.

          Zacks Equity Research

          Humana Extends Contract With Tivity Health, Spurs Healthcare

          by Zacks Equity Research

          Humana (HUM) continues to form strategic partnerships to improve the overall health of its Medicare Advantage members.

            Mark Vickery headshot

            Top Research Reports for Microsoft, Intel & UnitedHealth

            by Mark Vickery

            Today's Research Daily features new research reports on 16 major stocks, including Microsoft (MSFT), Intel (INTC) and UnitedHealth (UNH).

              Zacks Equity Research

              Tenet Healthcare Grows on Acquisitions, Lower Revenues Hurt

              by Zacks Equity Research

              Tenet Healthcare (THC) gains from buyouts, divestitures and strategic initiatives. However, fall in revenues and high level of debt continue to bother.

                Zacks Equity Research

                UnitedHealth (UNH) Arm to Buy Chilean Company for $2.8B

                by Zacks Equity Research

                UnitedHealth (UNH) is set to buy Empresas Banmedica in order to expand its international operations.

                  Zacks Equity Research

                  Anthem Buys HealthSun to Expand Medicare Business in Florida

                  by Zacks Equity Research

                  Anthem's (ANTM) buyout of HealthSun reflects its long-term strategy to grow in the Medicare Advantage business.

                    Zacks Equity Research

                    Can CVS Health Recover From the Shocks of 2016 & 17?

                    by Zacks Equity Research

                    CVS Health (CVS) looks for ways to return to growth.

                      Zacks Equity Research

                      Humana-Kindred Deal Keeps Shakeout Alive in Healthcare Space

                      by Zacks Equity Research

                      Humana's (HUM) agreement to acquire Kindred at Home aligns with its strategy to grow vertically.

                        Zacks Equity Research

                        WellCare Health (WCG) 2018 Guidance: What's in the Cards?

                        by Zacks Equity Research

                        Wellcare Health's (WCG) strong 2018 guidance instills investors' confidence in the company.

                          Zacks Equity Research

                          CVS-Aetna Deal Leading a Wave of Change in Hospital Sector

                          by Zacks Equity Research

                          Increased consolidation is being witnessed in the hospital sector as a defense against invasion by new comers.

                            Ryan McQueeney headshot

                            Discount Retail Stocks, LULU Earnings, & Healthcare Consolidation

                            by Ryan McQueeney

                            On today's episode of the Zacks Friday Finish Line, Content Writer Ryan McQueeney and Editor Maddy Johnson take on this week's biggest stories, including the latest earnings results from Dollar General (DG) and Lululemon (LULU), as well as major healthcare M&A deals involving CVS (CVS), Aetna (AET), and UnitedHealth (UNH).

                              Zacks Equity Research

                              UnitedHealth on A.M.Best's Radar After Buyout Announcement

                              by Zacks Equity Research

                              A.M.Best acknowledges UnitedHealth's(UNH) deleveraging strategy and earnings accretion from DaVita Medical Group acquisition.

                                Zacks Equity Research

                                Company News For Dec 7, 2017

                                by Zacks Equity Research

                                Companies In The News are: PLAY,OXM,HRB,DVA,UNH

                                  Zacks Equity Research

                                  UnitedHealth to Buy DaVita Medical, Expands Optum Business

                                  by Zacks Equity Research

                                  UnitedHealth's (UNH) intention to buy DaVita Medical reflects its continuous effort to build up a vertically integrated business model

                                    Benjamin Rains headshot

                                    UnitedHealth Continues Healthcare Shakeup With DaVita Deal

                                    by Benjamin Rains

                                    On Wednesday, only a few days after the CVS (CVS) and Aetna (AET) deal helped shine a light on the quickly changing healthcare industry, UnitedHealth Group (UNH) announced that it will buy a unit of DaVita Inc. (DVA) for nearly $5 billion.

                                      Zacks Equity Research

                                      Aetna, CVS Health Ink a Merger Agreement Worth $69 Billion

                                      by Zacks Equity Research

                                      Aetna's (AET) acquisition by CVS Health promises to expand the former's scale and size, and improve its access to health at lower cost.

                                        Zacks Equity Research

                                        Will Aetna Be Acquired by CVS Health to Rest Speculations?

                                        by Zacks Equity Research

                                        Aetna's (AET) likely acquisition by CVS Health promises to improve the company's scale and size, thus allowing it to better negotiate over drug prices.

                                          Zacks Equity Research

                                          UnitedHealth Keeps '17 Guidance & Issues '18 View, Stock Up

                                          by Zacks Equity Research

                                          UnitedHealth's (UNH) strong guidance for 2018 reflects its robust fundamentals amid a volatile regulatory backdrop.

                                            Zacks Equity Research

                                            Company News For Nov 28, 2017

                                            by Zacks Equity Research

                                            Companies in the news are: TIME,CUDA,TECD,UNH,MDP

                                              Zacks Equity Research

                                              Humana's Medicare Business Impresses, Public Exchange Hurts

                                              by Zacks Equity Research

                                              Although Humana (HUM) continues to grow on the back of Medicare and Medicaid expansions, threats from its exchange business weigh on both revenues and margins.

                                                Zacks Equity Research

                                                Can Health Insurers Continue to Look Past ACA Threats in Q4?

                                                by Zacks Equity Research

                                                Despite regulatory challenges, health insurance companies have the potential to outperform in Q4 on growing demand for government plans, reduced uninsured rates and aging U.S. population.

                                                  Zacks Equity Research

                                                  Anthem (ANTM) Grows on Membership, Rising Expenses Hurt

                                                  by Zacks Equity Research

                                                  Anthem's (ANTM) revenues gain from solid membership base and rising net investment income. However, public exchange loss and rising expenses continue to bother.